Skip to main content
. 2024 Mar 7;13:e85701. doi: 10.7554/eLife.85701

Appendix 2—table 2. Summary of the model parameters.

Symbol Interpretation Value(s) References
SARS-CoV-2 infection parameters:
βC transmission rate of SARS-CoV-2 0.46 days–1 Liu et al., 2020
γc SARS-CoV-2 recovery rate (mild cases) 1/7 days–1 Lauer et al., 2020; Rhee et al., 2020
ϵ SARS-CoV-2 incubation rate (latent period from exposed to infectious state) 1/5 days–1 Elias et al., 2021
θc Relative risk of SARS-CoV-2 transmission due to lockdown implementation 0.23 Salje et al., 2020
Pneumococcal colonization and invasion parameters:
βs transmission rate of antibiotic-sensitive strain 0.056 days–1
0.046 days–1
0.034 days–1
Davies et al., 2019; Olesen et al., 2020
f fitness of antibiotic-resistant strain (assuming there is a fitness cost on transmissibility) 0.9652
0.949
0.926
Dagan et al., 2008; Melnyk et al., 2015
βsf transmission rate of antibiotic-resistant strain calculated
θβ Relative risk of pneumococcal transmission due to lockdown implementation 1 or 0.75 assumed
γS=γR=γSS=γRR=γSR rate of natural bacterial clearance (assumed to be the same for antibiotic-sensitive and -resistant strains) 1/20 days–1
1/30 days–1
1/45 days–1
Abdullahi et al., 2012; Davies et al., 2019; Ekdahl et al., 1997; Högberg et al., 2021,Melegaro et al., 2004
q relative infectiousness with each strain for dually colonized 0.5 assumedColijn et al., 2010
c fraction of dually colonized returning to single-colonized upon reinfection 0.5 assumed (Colijn et al., 2010)
r probability of acquiring secondary bacterial carriage 0.5 assumed (Colijn et al., 2010)
ps probability of transmitting antibiotic-sensitive strain 0.5 assumed (Colijn et al., 2010)
psingle probability of a single infection 0.5 assumed (Colijn et al., 2010)
pinv pneumococcal invasion rate (summer and winter) [3x10-6 day–1,9x10-6 day–1] in the elderly and general population, and [1x10-6 day–1, 2.5x10-6 day–1] in <5 years-old Domenech de Cellès et al., 2019; Opatowski et al., 2013
SS+SR initial states – initial prevalence of the total pneumococcal carriage (antibiotic-sensitive and -resistant) in different populations 10%
20%
30%
Cohen et al., 2023; Rose et al., 2021; Rybak et al., 2022; Tinggaard et al., 2023; Wang et al., 2017
Antibiotic exposure parameters:
ω rate of antibiotic-induced pneumococcal clearance for sensitive strains(1/time before antibiotic action) 1/3 days–1 Kuitunen et al., 2023
r rate of return to antibiotic unexposed compartment (1/duration of antibiotic treatment) 1/7 days–1 Grant and Saux, 2021; Kuitunen et al., 2023
raz rate of return to antibiotic unexposed compartment (1/the remainder of how long azithromycin stays in the body) 1/11.5 days–1 calculated (Foulds et al., 1990; Girard et al., 2005)
τ baseline rate of antibiotic exposure in the community (France) 0.0014 average daily ppc (prescriptions per capita) Bara et al., 2022
a A reduction factor for antibiotic exposure in the community resulting from changes in healthcare-seeking behavior in response to the COVID-19 pandemic [0.51, 0.77, 0.84]to represent annual 13%, 18%, and 39% decrease observed in France Bara et al., 2022
paz A proportion of COVID-19 infected individuals in the community receiving azithromycin [0–0.20]testing between 0% and 20% Tsay et al., 2022; Wittman et al., 2023
Pathogenicity (invasive pneumococcal disease risk):
IPDrisk A reduction factor for the risk of developing an invasive pneumococcal disease (IPD) due to the absence of influenza-like-illnesses (ILIs) after lockdown implementation 1 (pre-lockdown)
0.2 (lockdown)
0.4 (post-lockdown) for an average of 0.5 in 2020
Shaw et al., 2023